Company intelligence / Profile preview

Israel Biotech Fund

Rehovot, Central District, Israelibf.fund ↗

Ownership: Private
Employees: ~21
Development stage: Other

Overview

Israel Biotech Fund is an active venture capital and private equity investor focused on Israeli and Israeli-related biotech/pharma companies developing therapeutic assets. Its portfolio includes firms at various clinical stages across oncology, immunology, neurology, and rare disease areas. The fund provides hands-on support through its network of industry leaders and has participated in several successful exits[1][3][8].

Modalities: Small moleculeMonoclonal antibodyCell therapy
Industry: Investors

Partnerships

Immunome Inc.Lonza GroupMölnlycke Health Care

Beyond the preview

Go deeper on Israel Biotech Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Israel Biotech Fund.

Explore the full profile